J Korean Diabetes.  2016 Jun;17(2):134-138. 10.4093/jkd.2016.17.2.134.

A Case of Fulminant Type 1 Diabetes during Pregnancy

• Oh TS
• Jung H
• Kang HR
• Kim TK
• Kwon MJ
• Lee SH
• Park JH

• KMID: 2328579
• DOI: http://doi.org/10.4093/jkd.2016.17.2.134

Abstract

Fulminant type 1 diabetes is characterized by acute onset, no evidence of islet-related autoantibodies, low glycated hemoglobin(HbA1c) level at onset, and metabolic complications such as diabetic ketoacidosis. Fulminant type 1 diabetes development during pregnancy can result in severe maternal and fetal complications. Most of the patients with fulminant type 1 diabetes during pregnancy have been reported in Japan. In Korea, reports of fulminant type 1 diabetes during pregnancy are uncommon. We report a 36-year-old Korean woman with fulminant type 1 diabetes developed at 32 weeks of gestation who demonstrate a good outcome.

Keyword

Fulminant; Pregnancy; Type 1 diabetes

MeSH Terms

Adult
Autoantibodies
Diabetic Ketoacidosis
Female
Humans
Japan
Korea
Pregnancy*
Autoantibodies

Reference

References

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26(Suppl 1):S5–20.

2. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med. 2000; 32:539–43.

3. Tanaka S, Endo T, Aida K, Shimura H, Yokomori N, Kaneshige M, Furuya F, Amemiya S, Mochizuki M, Nakanishi K, Kobayashi T. Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset. Diabetes Care. 2004; 27:1936–41.

4. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000; 342:301–7.

5. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003; 26:2345–52.

6. Lee JH, Koh GP, Yang JK, Kim KH, Im DM, Park KY. A typical case of fulminant type 1 diabetes mellitus. J Korean Diabetes Assoc. 2007; 31:175–9.

7. Rhee SY, Chon S, Koh G, Oh S, Woo JT, Kim JW, Kim YS. A case of fulminant type 1 diabetes mellitus. Korean J Med. 2006; 70:342–6.

8. Kim NH, Kim HY, Seo JA, Kim NH, Choi KM, Baik SH, Choi DS, Kim SG. A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan. Diabetes Res Clin Pract. 2009; 86:e43–5.

9. Yu HK, Nam M, Shim WS, Chung HJ, Kim EJ, Hong SB, Kim YS. A case of fulminant type 1 diabetes associated with pregnancy. J Korean Diabetes Assoc. 2007; 31:180–3.

10. Kim HS, Lee TY, Kim EY, Choi JH, Kim SY, Hwang YC, Kang JH, Ahn KJ, Chung HY, Jeong IK. Fulminant type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome. Diabet Med. 2012; 29:1335–8.

11. Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T, Hanafusa T. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab. 2006; 91:471–6.

12. Shimizu I, Makino H, Osawa H, Kounoue E, Imagawa A, Hanafusa T, Kawasaki E, Fujii Y. Association of fulminant type 1 diabetes with pregnancy. Diabetes Res Clin Pract. 2003; 62:33–8.

13. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol. 2000; 18:367–91.

14. Imagawa A, Hanafusa T, Makino H, Miyagawa JI, Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005; 48:290–3.

15. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA. 2001; 285:1153–4.

16. Sano H, Terasaki J, Tsutsumi C, Imagawa A, Hanafusa T. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract. 2008; 79:e8–9.

17. Akatsuka H, Yano Y, Gabazza EC, Morser J, Sasaki R, Suzuki T, Fujiwara R, Katsuki A, Takei Y, Sumida Y. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res Clin Pract. 2009; 84:e50–2.

18. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991; 165:1667–72.

19. Zhang L, Sugiyama T, Murabayashi N, Umekawa T, Ma N, Kamimoto Y, Ogawa Y, Sagawa N. The inflammatory changes of adipose tissue in late pregnant mice. J Mol Endocrinol. 2011; 47:157–65.

20. Kamalakannan D, Baskar V, Barton DM, Abdu TA. Diabetic ketoacidosis in pregnancy. Postgrad Med J. 2003; 79:454–7.